Also, we studied AMM-ULN and SUA as predictors of overt HE in patients by univariate and multivariate logistic regression analysis
Liver function effects of SGLT2 inhibitor and GLP-1 receptor agonist combination treatment in patients with type 2 diabetes (post hoc analysis of RECAP study)
Most patients notice cravings, snacking and food noise drop within days of starting
Before getting into those, a notable award recognition related to GLP-1 drug expansion from diabetes to obesity
10.1016/j.orcp.2015.03.005 [DOI] [PubMed] [Google Scholar] 21.Da Porto A, Casarsa V, Colussi G, Catena C, Cavarape A, Sechi L (2020) Dulaglutide reduces binge episodes in type 2 diabetic patients with binge-eating disorder: a pilot study
Discovery of the GI effects of GLP-1: an historical perspective